Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DCleu)

Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DCleu)

Copyright © 2020 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 217(2020) vom: 01. Aug., Seite 108467
1. Verfasser: Ansprenger, Christian (VerfasserIn)
Weitere Verfasser: Amberger, Daniel Christoph, Schmetzer, Helga Maria
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article AML DC Immunotherapy Leukemia derived DC Granulocyte-Macrophage Colony-Stimulating Factor 83869-56-1
Online verfügbar Volltext